75PHARMA LIMITED
🏛️Establishedactive
13240109 · ltd · incorporated 2021-03-02
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Dec 2024
Net worth
£-243.9k
book net assets
Opportunity
77/100
Strong
What this business does
Primary activity: SIC 46460
Sector: Wholesale & retail
Investor take
Pass (distressed without resilience)Distressed active trading company — structural issues outweigh the discount.
Opportunity 77/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
4 officers (2 active, 4 linked, 4 with DOB)
90
Ownership & PSC
1 active PSC(s) of 3 total, 3 with control declared
90
Director network
1 connected companies via shared directors
48
Filing history
27 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
77/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
65
Adequate — check latest filings for context.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · FRS 102Negative net assets
Liabilities exceed assets by £243,871
Key financials
2 years extracted from filed iXBRL accountsCash
£5k
Net Worth
-£244k
Current Assets
£34k
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total assets | £-243.9k | — |
| Current assets | £33.7k | — |
| Cash | £5.4k | — |
| Debtors | £28.3k | — |
| Net assets | £-243.9k | — |
| Average employees | — | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
4 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
2
filings
- • 1 confirmation-statement
- • 1 officers
Last 180 days
3
filings
- • 1 confirmation-statement
- • 1 officers
- • 1 accounts
Counts from Companies House filing history.
Corporate timeline (27 events)Click to expand
- 2026-02-18➖PALL, Sunita resigneddirector
- 2026-02-18📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-12-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-02-07📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-02-07📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-02-07📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2024-12-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-07-20📄memorandum-articlesincorporation · MA
- 2023-07-20📄resolutionresolution · RESOLUTIONS
- 2023-07-13📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-07-12📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-07-12📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-07-11➕NEVALA, Niko Johannes appointeddirector
- 2023-07-11➕PALL, Sunita appointeddirector
- 2023-07-11➖SORENSEN, Tony Ivan resigneddirector
- 2022-09-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-11-09📄change-person-director-company-with-change-dateofficers · CH01
- 2021-11-08📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2021-10-11📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2021-10-11📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2021-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2021-10-07📄change-person-director-company-with-change-dateofficers · CH01
- 2021-10-06📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2021-03-02🏢Company incorporatedAs 75PHARMA LIMITED
- 2021-03-02➕RUOKOSTENPOHJA, Pasi Petteri appointeddirector
- 2021-03-02➕SORENSEN, Tony Ivan appointeddirector
Owner dependency
66/100
High — earn-out structure requiredMaterial founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
FACTORS
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Senior director age: Director aged approximately 59 — approaching natural succession window.
Succession & seller-readiness
46/100
Moderate signalSome succession indicators present. Worth watching; approach if sector/strategy fits.
SIGNALS
- secondaryFounder aged 58+: Senior director is approximately 59. Early succession window.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Group structure
75pharma Group Limited holds 25-50% — a significant corporate investor but not a controlling parent.
🏛️significant stake
75pharma Group Limited
Corporate parent · holds 25-50% shares · board control
⬇
75PHARMA LIMITED
This company · 13240109
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
75pharma Group Limited Corporate entity | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 01/07/2024 |
2 historic (ceased) PSCs
- Mr Tony Ivan Sorensenceased 01/07/2024· 25-50% shares · 25-50% voting
- Mr Pasi Petteri Ruokostenpohjaceased 01/07/2024· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Wholesale & distribution · SW postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 24 AIRCON LTD→ 12489520 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| 2STL LIMITED→ 13197770 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| 316 STARTUPS LIMITED→ 12684989 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| 3H FAMILY LTD→ 16526315 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 469 TRADE HUB LTD→ 16325802 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| 4GD UK LTD→ 12648383 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| 4KIX LIMITED→ 14266599 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 75PH IMPACT LIMITED→ 16109701 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| 7TO1 LIMITED→ 14821248 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| 8020 IM SOLUTIONS LTD→ 10818241 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| A1 PHARMA LTD→ 12712639 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| A1 TOOLS AND FIXINGS LIMITED→ 03851305 · est 1999 · no financials extracted | — | — | — | — | 26y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2021-03-02
Jurisdictionengland-wales
Primary SIC46460 — SIC 46460
Registered office
123 Buckingham Palace Road
London
SW1W 9SH
United Kingdom
Filing status
Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2027-03-15
Last: 2026-03-01
Officers (2 active · 2 resigned)
NEVALA, Niko Johannes→
Activedirector · ~40y · appointed 2023-07-11
View their other companies + combined net worth →
RUOKOSTENPOHJA, Pasi Petteri→
Activedirector · ~59y · appointed 2021-03-02
View their other companies + combined net worth →
PALL, Sunita→
Resigneddirector · ~37y · appointed 2023-07-11 · resigned 2026-02-18
SORENSEN, Tony Ivan→
Resigneddirector · ~52y · appointed 2021-03-02 · resigned 2023-07-11
Click a director name to see their full track record across all companies.
Recent filings (27 total)
confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-24
termination-director-company-with-name-termination-date
officers · TM01
2026-02-18
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-12-04
confirmation-statement-with-updates
confirmation-statement · CS01
2025-04-02
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-02-07
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-02-07
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC02
2025-02-07
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-12-30
confirmation-statement-with-updates
confirmation-statement · CS01
2024-03-28
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-12-29
memorandum-articles
incorporation · MA
2023-07-20
resolution
resolution · RESOLUTIONS
2023-07-20
appoint-person-director-company-with-name-date
officers · AP01
2023-07-13
appoint-person-director-company-with-name-date
officers · AP01
2023-07-12
termination-director-company-with-name-termination-date
officers · TM01
2023-07-12